Journal Editorial Policies

Pharma Vision will release two issues every year. Editors along with associate editors initially assess each paper upon submission to see whether it is appropriate for formal review. Before moving on to formal peer review, manuscripts with insufficient originality, substantial scientific or technical faults, or irrelevant topics are rejected. The authors must make sure that their writing is fully original, and if they have borrowed from the work of others, they must properly credit or site it. The order in which the contributors are listed should reflect their relative contributions to the study and the creation of the manuscript.

Submissions are accepted on the condition that the authors prepared their manuscripts in accordance with ethical standards. All manuscripts will be recognised as received within a week, and authors will be informed if the work will move forward to peer review. The raw data related to an article may be requested from authors for editorial review. If possible, authors should be ready to make these data accessible to the public, and in any case, they should be ready to keep these data for a fair amount of time after publication. The author(s) is/are responsible for all claims made in their work and should be prepared to defend them in public if questioned. The journal has the right to make any additional formal and grammatical modifications to an article that is accepted for publication. It is appropriate to acknowledge people who helped produce a work but are not considered authors. It is also important to acknowledge the organisations that contributed funding and/or other resources. Prior to submission, the final draft of the manuscript needs to be approved by all authors. It is therefore presumed that once a document is submitted, all authors have read it and given their consent to its submission. The manuscript should include the corresponding author's contact information. In the manuscript, a declaration of conflicts of interest should be made.

The review process is a crucial step in the publication process since it aids editors in choosing articles and gives authors the chance to make edits to their work. The Pharma Vision follow a double-blind review procedure, keeping authors and reviewer’s identities unknown to one another. The identity of the author(s) is concealed from the reviewers and removed from the paper during the review process. The reviewer is just given the text; there is no further material that could help them determine who the author is. Following the review of the article, reviewers are given a certificate of review.

The authors receive the review reports. If a manuscript needs to be improved, the editor recommends further editing in a letter to the author(s). The original manuscript, the amended manuscript, and the review reports are sent to the editor upon receipt of the author(s) updated manuscript. The updated manuscript will get a final "Accept" or "Reject" decision from the editor-in-chief.

Scientific Quality and Credibility

Data given in the paper or cited in other papers should be reliable and support the paper's arguments and conclusions. The manuscript being evaluated need to be written in specialised terminology appropriate for a scientific journal.

Suitability for the Journal

The article under evaluation should easily fall within the objectives and purview of the journal Pharma Vision, to which it has been submitted.

Authors

Authors should disclose their affiliations and work at recognised private or public institutions.

Ethical considerations

Pharma Vision requires authors to certify, at the time their paper is submitted and before it is published, that they have adhered with all necessary ethical criteria regarding identifiable human subjects and trials involving humans and animals.

Want more Google Sites designs, tutorials and helpful information for free?

Visit ARC Templates now!